Hepcdac 60mg Tablet

Hepcdac 60mg Tablet may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:
Fatigue
Headache
Nausea
Insomnia (difficulty in sleeping)
Anemia (low number of red blood cells)
Contact your doctor immediately if you experience any severe or unusual side effects.

The doctor determines the dosage of Hepcdac 60mg Tablet as per the patient's health and other medical conditions. Take this medicine at the same time every day as prescribed by your doctor for effective results. It can be taken orally, with or without food. In case of an overdose, contact your doctor immediately.

If you miss a dose of Hepcdac 60 mg tablet, make sure to consult your healthcare provider. Do not double the dose to catch up.

At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.

Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.

Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.


We currently ship to:

Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!

1. Herbst, D. A., & Reddy, K. R. (2013). NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection. Expert opinion on investigational drugs, 22(10), 1337-1346.
2. Sulkowski, M. S., Gardiner, D. F., Rodriguez-Torres, M., Reddy, K. R., Hassanein, T., Jacobson, I., ... & Grasela, D. M. (2014). Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. New England Journal of Medicine, 370(3), 211-221.
3. Vyas, B. H., Darji, N. H., Rana, D. A., Vyas, K. Y., & Malhotra, S. D. (2021). Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients. Perspectives in Clinical Research, 12(2), 76-82.
4. Elliott, W. T. (2015). Daclatasvir Tablets (Daklinza). Internal Medicine Alert, 37(21).
5.Pellicelli, A. M., Montalbano, M., Lionetti, R., Durand, C., Ferenci, P., D’Offizi, G., ... & Angelico, M. (2014). Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late. Digestive and Liver Disease, 46(10), 923-927.